C210 (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg)
Pill with imprint C210 is Pink, Capsule-shape and has been identified as Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg. It is supplied by Cipla USA Inc..
Efavirenz/emtricitabine/tenofovir is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Efavirenz/emtricitabine/tenofovir 600 mg / 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C210
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
- Imprint
- C210
- Strength
- 600 mg / 200 mg / 300 mg
- Color
- Pink
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- Manufacturer
- Genvion Corporation
- National Drug Code (NDC)
- 69097-0210
Related Images for "C210"
More about efavirenz / emtricitabine / tenofovir
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 106 Reviews
- Drug class: antiviral combinations
Consumer resources
- Patient Information
- Efavirenz, emtricitabine, and tenofovir (Advanced Reading)
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Other brands
- Atripla
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.